[CRVS] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
25-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- 379.16%
YoY- 347.55%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -10,673 -11,752 -11,580 27,347 -9,796 -10,611 -12,935 -12.01%
Tax -1,604 -1 -3 -143 0 0 0 -
NP -10,673 -11,752 -11,580 27,347 -9,796 -10,611 -12,935 -12.01%
Tax Rate - - - 0.52% - - - -
Total Cost 10,673 11,752 11,580 -27,347 9,796 10,611 12,935 -12.01%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -0.24 -0.28 -0.34 0.92 -0.33 -0.36 -0.44 -33.21%
EPS Diluted -0.24 -0.28 -0.34 0.92 -0.33 -0.36 -0.44 -33.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.